Women assigned to home-based, self-obtained vaginal swab collection were substantially more likely to be rescreened than were those assigned to clinic-based testing.
Repeat testing for Chlamydia trachomatis 3 months following treatment is recommended, because reinfection rates are high. To assess whether retesting rates can be improved by home collection of vaginal swabs, investigators randomized 1292 women (mean age, 22; >90% black) who tested positive for chlamydia at sexually transmitted disease (STD) and family planning clinics in New Orleans, Jackson, Mississippi, and St Louis to be rescreened at a return clinic visit or with a self-collection mail-in kit.
Significantly more women who were assigned to home-based screening than to clinic-based screening were rescreened (27% vs. 19% of women from STD clinics and 41% vs. 21% from family planning clinics). Rescreening rates were even higher among women …
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)